RESEARCH TRIANGLE PARK, N.C., Dec. 13, 2022 -- Pappas Capital, a global venture capital and commercial development firm, announced today the appointment of Richard Staub as Venture Partner. His appointment...
PRINTed Nanoparticles Delivery Multiple Punches to Treat Prostate Cancer
Using technologies common to the semiconductor industry, a team of
investigators at the University of North Carolina at Chapel Hill and
Liquidia Technologies has created a polymer nanoparticle that can
encapsulate large loads of therapeutic molecules that may have use in
treating prostate cancer. The research, led by Joseph DeSimone,
co-principal investigator of the Carolina Center for Cancer
Nanotechnology, was published in the journal Nano Letters.
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.